We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFEET.L Regulatory News (FEET)

  • There is currently no data for FEET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews on Fundsmith Emerging Equities

18 Nov 2021 08:00

RNS Number : 7322S
Fundsmith Emerging Equities Tst PLC
18 November 2021
 

 

London, UK, 18 November 2021

 

Edison reviews on Fundsmith Emerging Equities Trust (FEET)

Fundsmith Emerging Equities Trust (FEET) has evolved from an emerging markets (EM) consumer-driven growth story since launch in 2014. Its strategy remains to own high-quality companies, but a number of changes in emphasis have been made. The managers have made the portfolio more focused by number of holdings (38 at end-September 2021) and the weighting in technology and healthcare has increased. The team stresses that the fund suits investors with a long-term time horizon, as the underlying strong portfolio fundamentals lead to it owning businesses with superior operating performance, regardless of short-term market momentum. A combination of the recent robust performance of FEET's holdings and a lengthy correction in China's equity market (where FEET at c 15% is underweight the benchmark at c 19pp) has resulted in a strengthening of the fund's absolute and relative performance.

 

EM has been a 'mixed bag' in terms of performance in the past few years, with big divergences between countries. The differentiated approach and the high Indian exposure (c 46%, overweight the benchmark by 34pp, which is an outcome rather than a policy amendment (made in 2021) have started to pay off, as performance has strengthened. The increased portfolio concentration of 25-40 stocks (from 35-55), following the investment policy amendment, allows the managers to focus on the highest conviction stocks, while managing risk prudently.

 

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Victoria Chernykh +44 (0)20 3681 2522

investmenttrusts@edisongroup.com

 

Sarah Godfrey +44 (0)20 3681 2519

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFFRLALDLIL
Date   Source Headline
11th Nov 20221:03 pmRNSResults of the General Meeting
2nd Nov 20221:19 pmRNSMonthly Fact Sheet as at 31 October 2022
1st Nov 20229:37 amRNSTotal Voting Rights
11th Oct 20227:21 amRNSPublication and Posting of Circular
5th Oct 20229:44 amRNSMonthly Fact Sheet as at 30 September 2022
3rd Oct 20227:30 amRNSTotal Voting Rights
21st Sep 20221:02 pmRNSHolding(s) in Company
14th Sep 20228:25 amRNSProposal to Liquidate (Replacement)
14th Sep 20227:00 amRNSProposal to Liquidate
2nd Sep 202212:16 pmRNSMonthly Fact Sheet as at 31 August 2022
1st Sep 20229:29 amRNSTotal Voting Rights
5th Aug 20227:00 amRNSHalf-year Report
2nd Aug 202211:04 amRNSMonthly Fact Sheet as at 29 July 2022
1st Aug 202210:20 amRNSTotal Voting Rights
7th Jul 202212:08 pmRNSBlock listing Interim Review
5th Jul 20229:47 amRNSCompliance with Market Abuse Regulation
4th Jul 20221:38 pmRNSMonthly Fact Sheet as at 30 June 2022
1st Jul 202212:49 pmRNSTotal Voting Rights
8th Jun 20222:09 pmRNSDirector/PDMR Shareholding
6th Jun 20222:33 pmRNSMonthly Fact Sheet as at 31 May 2022
1st Jun 202210:29 amPRNNet Asset Value(s)
1st Jun 20227:27 amRNSTotal Voting Rights
31st May 202210:09 amPRNNet Asset Value(s)
30th May 202210:22 amPRNNet Asset Value(s)
27th May 20221:16 pmRNSDirector/PDMR Shareholding
27th May 20229:34 amPRNNet Asset Value(s)
26th May 20229:47 amPRNNet Asset Value(s)
25th May 20224:45 pmRNSResult of AGM
25th May 20222:56 pmRNSDirectorate Change
25th May 202210:01 amPRNNet Asset Value(s)
24th May 202210:23 amPRNNet Asset Value(s)
23rd May 20229:52 amPRNNet Asset Value(s)
10th May 20224:47 pmRNSHolding(s) in Company
9th May 202210:35 amRNSMonthly Fact Sheet as at 29 April 2022
3rd May 202210:31 amRNSTotal Voting Rights
14th Apr 202210:24 amPRNNet Asset Value(s)
13th Apr 202210:21 amPRNNet Asset Value(s)
12th Apr 202211:00 amPRNNet Asset Value(s)
11th Apr 202210:47 amPRNNet Asset Value(s)
8th Apr 202210:17 amPRNNet Asset Value(s)
7th Apr 202210:27 amPRNNet Asset Value(s)
6th Apr 202210:38 amPRNNet Asset Value(s)
5th Apr 202210:50 amPRNNet Asset Value(s)
4th Apr 20221:52 pmRNSMonthly Fact Sheet as at 31 March 2022
4th Apr 202210:54 amPRNNet Asset Value(s)
1st Apr 202210:27 amPRNNet Asset Value(s)
1st Apr 20228:41 amRNSTotal Voting Rights
31st Mar 202210:43 amPRNNet Asset Value(s)
30th Mar 202210:27 amPRNNet Asset Value(s)
29th Mar 202210:13 amPRNNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.